Related News:
- New phase III data show Roche’s Vabysmo rapidly…
- New two-year data for Roche’s Vabysmo and Susvimo…
- New two-year data for Roche’s Vabysmo and Susvimo…
- Roche’s Vabysmo prefilled syringe (PFS) approved in…
- New two-year data confirm Roche’s Vabysmo improves…
- FDA approves Roche’s Vabysmo, the first bispecific…